downgrad equal-weight
hill-rom execut line transform upgrad
thesi materi outperform coverag modest
upsid versu consensu expect downgrad
equal-weight adjust price target
thesi consensu downgrad equal-weight prior
overweight rate base thesi hill-rom transform
diversifi durabl busi improv growth margin profil
would lead multipl expans share out-performance see note
last month share outperform
devic coverag point respect continu see
steadi transform busi top-line grower
grower see oper margin target
achiev howev street number impli top-line growth
versu estim consensu estim impli oper margin
versu model estim ep estim
street see modest upsid consensu number see
better risk-reward elsewher coverag downgrad hill-rom
equal-weight adjust price target
tale two smid cap transform stori see better risk-reward
within coverag hill-rom smid cap
multi-year transform stori continu see hill-rom lrp
achiev discuss follow plan announc howev see
upsid year consensu hill-rom ep estim versu
hill-rom trade ev/ebitda
see greater upsid hill-rom expos
lower growth end market grow haemonet
increas exposur plasma current revenu increas
faster grow end market see faster top
bottom line growth rate next year
upgrad
continu see top-line guidanc achiev hill-rom
believ manag provid risk-adjust guidanc year
medic technolog unit state america
unless otherwis note metric base modelwar
consensu data provid thomson reuter estim
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
appear back half load guidanc core growth impli
increment core revenu growth come pipelin
product vision integr tabl motion connex centrella
expect contribut revenu vs
impli remaind core busi continu grow
comfort given pt market growth off-set pt
guidanc impli signific momentum acceler given
flattish guid believ manag tri reduc quarterli
volatil establish track record consist meet expect
quarterli annual basi guidanc flat core growth
easiest comp year rais investor question quarter
neg impact hurrican phase
larg order frontlin pt core growth adjust
subsequ quarter like need see pt acceler sequenti
momentum magnitud acceler larg factor could help
name better contribut centrella ii season rental
busi iii mortara acquisit becom organ
see modest upsid consensu ep estim model bp
oper margin expans given remain synergi mortara mix
benefit divestitur new product revers footprint consolid
headwind aspen progress organ initi start ep
see upsid organ growth oper
leverag off-set higher tax rate arriv ep
upper rang guidanc consensu note tax
reform would expect hill-rom tax rate trend toward tax
rate could worth ep versu rate model
downgrad equal-weight rais price target clear
believ hill-rom stori structur chang rather
transform increasingli reflect consensu estim
therefor downgrad share equal-weight continu believ solid
execut help hill-rom multipl switch ev/ebitda base
valuat given compani leverag net debt ebitda
continu believ compani discount turn
ev/ebitda basi narrow follow execut lrp price
target reflect ev/ebitda multipl estim discount
median current multipl smid cap coverag given lower ebitda
growth ebitda growth versu median higher leverag
multipl re-rat given divers improv growth
multipl re-rat given divers improv growth
price target reflect ev/ebitda multipl
discount averag current multipl smid cap
coverag given lower ebitda growth higher leverag
capital-expenditure remain strong drive upsid margin earn capit sale
growth continu current momentum intermedi term grow
mid-singl digit new product launch perform better expect
underli margin surpass top hill-rom long-rang plan given upsid
welch allyn organ initi hill-rom manag remain focus
addit deal compani delev
hill-rom growth stabil mid-singl digit north america growth slow
given limit bed contribut tailwind welch allyn surgic
new product move hill-rom structur organ growth rate
welch allyn synergi mix cost initi drive margin
improv stabil growth visibl margin improv drive
long-term plan materi sale see moder growth
surgic solut see neg growth north america
moder organ initi materi manag expect leav
welch allyn driven improv mix synergi multipl remain
depress given compani high debt load
hill-rom multipl re-rat
growth move higher volatil
decreas hill-rom sale base
diversifi number driver
increas hill-rom organ
lrp achiev
achiev prior lrp target year earli
hill-rom new lrp call growth
trend toward
along oper margin
target see new lrp
achiev product pipelin
robust time around end market
mix improv
support healthi capit
hospit capital-expenditure environ hill-
rom revenu expos hospit
centrella contribut
sale expect contribut
sale drive pt core growth
progress cost restructur on-going
uptak recent product launch
shift capital-expenditure spend environ
risk achiev price
futur sale lower expect
european sale continu declin
organ leverag prove difficult
materi shift capital-expenditure environ given
dollar million except per share data
total revenu
less net incom non-controlling interest
net incom sharehold
dollar million except per share data
dollar million except per share data
invest invest secur
softwar net
note receiv net discount
accru pension postretir benefit
addit paid capit
dollar million except per share data
net realiz capit loss gain equiti method invest incom loss
provis defer incom tax
chang oper asset liabil
net provid oper activ
capit expenditur purchas intang
proce dispos properti equip leas
proce sale non-strateg asset
payment acquisit busi net cash
invest purchas capit call
proce invest sale matur
net use invest activ
net chang short-term debt net debt issuanc cost
payment long-term debt net proce settlement interest rate swap includ payment/borrow revolv
distribut non-controlling interest partner
net chang equiti
effect exchang rate ce
net chang
equival bop
equival eop
price target reflect ev/ebitda estim turn
premium compani current multipl discount back one year wacc
upsid risk price target includ higher price benefit nexsi ii
identif addit cost opportun iii capit deploy downsid
risk includ nexsi disappoint ii cost save fail materi iii blood
bank slow materi iv teg disappoint
